Proteasome inhibition with bortezomib: an effective therapy for severe antibody mediated rejection after renal transplantation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Proteasome inhibition with bortezomib: an effective therapy for severe antibody mediated rejection after renal transplantation

Published:2012-03-01 Issue:03 Volume:77 Page:246-253
ISSN:0301-0430
Container-title:Clinical Nephrology
language:en
Short-container-title:CN

Author:

Sureshkumar Kalathil K.,Hussain Sabiha M.,Marcus Richard J.,Ko Tina Y.,Khan Akhtar S.,Tom Kusum,Vivas Carlos A.,Parris George,Jasnosz Katherine M.,Thai Ngoc L.

Publisher

Dustri-Verlgag Dr. Karl Feistle

Subject

Nephrology,General Medicine

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimal Immunosuppression Strategy in the Sensitized Kidney Transplant Recipient;Journal of Clinical Medicine;2021-08-18

2. Structure–Activity Relationships of Noncovalent Immunoproteasome β5i-Selective Dipeptides;Journal of Medicinal Chemistry;2020-10-23

3. Acute Rejection Following Kidney Transplantation: State-of-the-Art and Future Perspectives;Current Pharmaceutical Design;2020-08-31

4. Antibody-Mediated Rejection Treatment With Bortezomib in Renal Transplant Recipients: A Single-Center 24-Month Follow-up Case Report;Transplantation Proceedings;2020-05

5. The Preliminary Results of Bortezomib Used as A Primary Treatment for An Early Acute Antibody-Mediated Rejection after Kidney Transplantation—A Single-Center Case Series;Journal of Clinical Medicine;2020-02-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP